USP22 also deubiquitinates RIPK3, which causes high hyperglycemia to trigger damage to podocyte intercellular collagenization while targeting USP22 increased the amount of ubiquitinated degradation of RIPK3 and protected podocytes97. This evidence concerns the gene USP22 and Hyperglycemia.